SPONSOR
Peng Zhang
Total Trials
2
Recruiting
2
Phases
Phase 2, EARLY_Phase 1
Conditions studied: EGFRNon-Small Cell Lung CancerLocally Advanced Non-Small Cell Lung CancerPemetrexedCarboplatinBevacizumabAntineoplastic AgentsTyrosine Kinase InhibitorToxic Epidermal Necrolysis
NCT06755684 Phase 2
Recruiting
Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer
EGFR
NCT06119490 EARLY_Phase 1
Recruiting
Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis
Toxic Epidermal Necrolysis